4.22
Organogenesis Holdings Inc stock is traded at $4.22, with a volume of 626.94K.
It is down -0.71% in the last 24 hours and down -15.09% over the past month.
Organogenesis Holdings Inc is a regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the advanced wound care, surgical, and sports medicine markets. The company's portfolio of regenerative medicine products in the advanced wound care category includes Apligraf, Dermagraft, PuraPly AM, CYGNUS Dual, etc., and the sports medicine products include NuShield as a surgical barrier and PuraForce as a reinforcement matrix in targeted soft tissue repairs; and Affinity, Novachor, PuraPly MZ, PuraPly AM, and PuraPly SX for management of open wounds in the surgical setting. The company operates in a single segment, that is, regenerative medicine.
See More
Previous Close:
$4.25
Open:
$4.2
24h Volume:
626.94K
Relative Volume:
0.35
Market Cap:
$549.17M
Revenue:
$433.14M
Net Income/Loss:
$4.95M
P/E Ratio:
118.21
EPS:
0.0357
Net Cash Flow:
$6.55M
1W Performance:
+12.53%
1M Performance:
-15.09%
6M Performance:
+37.46%
1Y Performance:
+51.25%
Organogenesis Holdings Inc Stock (ORGO) Company Profile
Name
Organogenesis Holdings Inc
Sector
Phone
781-575-0775
Address
85 DAN ROAD, CANTON, MA
Compare ORGO with other stocks
Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
---|---|---|---|---|---|---|
![]()
ORGO
Organogenesis Holdings Inc
|
4.22 | 549.17M | 433.14M | 4.95M | 6.55M | 0.0357 |
![]()
ZTS
Zoetis Inc
|
148.67 | 67.28B | 9.26B | 2.49B | 2.30B | 5.47 |
![]()
HLN
Haleon Plc Adr
|
10.22 | 45.62B | 14.35B | 1.85B | 0 | 0.4023 |
![]()
TAK
Takeda Pharmaceutical Co Adr
|
14.71 | 45.01B | 30.25B | 1.37B | 5.08B | 0.4257 |
![]()
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
13.65 | 15.60B | 16.54B | -1.64B | 749.00M | -1.45 |
![]()
UTHR
United Therapeutics Corp
|
284.73 | 12.77B | 2.76B | 1.11B | 898.10M | 22.77 |
Organogenesis Holdings Inc Stock (ORGO) Upgrades & Downgrades
Date | Action | Analyst | Rating Change |
---|---|---|---|
Jun-28-24 | Initiated | Lake Street | Buy |
Feb-07-24 | Initiated | Cantor Fitzgerald | Overweight |
Jun-15-23 | Initiated | Morgan Stanley | Equal-Weight |
May-24-23 | Upgrade | BTIG Research | Neutral → Buy |
Nov-10-22 | Downgrade | BTIG Research | Buy → Neutral |
Aug-10-22 | Downgrade | Oppenheimer | Outperform → Perform |
Jan-10-20 | Initiated | SVB Leerink | Outperform |
Aug-26-19 | Resumed | Credit Suisse | Outperform |
May-02-19 | Initiated | Credit Suisse | Outperform |
Apr-17-19 | Initiated | Oppenheimer | Outperform |
Apr-11-19 | Initiated | SunTrust | Buy |
View All
Organogenesis Holdings Inc Stock (ORGO) Latest News
Amniotic Membrane Market Set to Witness Significant Growth - openPR.com
Organogenesis Holdings Inc. (NASDAQ:ORGO) Shares Acquired by O Shaughnessy Asset Management LLC - Defense World
Wellington Management Group LLP Grows Stock Holdings in Organogenesis Holdings Inc. (NASDAQ:ORGO) - Defense World
Organogenesis Holdings Inc. (NASDAQ:ORGO) Shares Bought by American Century Companies Inc. - Defense World
Organogenesis Supports CMS' Local Coverage Determination Implementation Delay to Review Coverage Policies to Maintain Patient Access with High Quality Evidence of Effectiveness - The Manila Times
Medicare Coverage Shift for Wound Care Products Paused: What This Means for Patient Access - Stock Titan
Sei Investments Co. Cuts Stock Holdings in Organogenesis Holdings Inc. (NASDAQ:ORGO) - Defense World
High Growth Tech Stocks In The US To Watch April 2025 - simplywall.st
Prudential Financial Inc. Has $761,000 Stock Holdings in Organogenesis Holdings Inc. (NASDAQ:ORGO) - Defense World
Organogenesis Holdings Inc. to Report First Quarter of Fiscal Year 2025 Financial Results on May 8, 2025 - The Manila Times
Organogenesis Sets Key Q1 Earnings Date: What Investors Should Watch - Stock Titan
Insider-Favored Growth Companies Including Organogenesis Holdings And Two More - simplywall.st
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Shareholders of Organogenesis Holdings Inc. a Class Action Lawsuit and a Lead Plaintiff Deadline of February 8, 2022ORGO - ACCESS Newswire
Virtu Financial LLC Invests $38,000 in Organogenesis Holdings Inc. (NASDAQ:ORGO) - Defense World
Charles Schwab Investment Management Inc. Has $2.96 Million Stake in Organogenesis Holdings Inc. (NASDAQ:ORGO) - Defense World
Organogenesis Highlights Strategic Focus in Investor Presentation - TipRanks
Wound Care Biologics Market Overall Study Report 2025-2032 | - openPR.com
Organogenesis Holdings Inc. (NASDAQ:ORGO) Stock Position Raised by Bank of New York Mellon Corp - Defense World
Bank of New York Mellon Corp Purchases 109,762 Shares of Organogenesis Holdings Inc. (NASDAQ:ORGO) - The AM Reporter
Organogenesis Holdings Inc.(NasdaqCM:ORGO) added to S&P Biotechnology Select Industry Index - MarketScreener
Organogenesis Holdings: Solid Finances Protect From Uncertain Environment (NASDAQ:ORGO) - Seeking Alpha
Organogenesis (NASDAQ:ORGO) Stock Price Down 2.1% – What’s Next? - Defense World
Analyzing Organogenesis (NASDAQ:ORGO) and OnKure Therapeutics (NASDAQ:OKUR) - Defense World
Rhumbline Advisers Acquires 7,621 Shares of Organogenesis Holdings Inc. (NASDAQ:ORGO) - Defense World
Morgan Stanley Increases Organogenesis (NASDAQ:ORGO) Price Target to $6.00 - Defense World
Organogenesis director Michael Driscoll sells $127,535 in stock By Investing.com - Investing.com South Africa
Organogenesis director Michael Driscoll sells $127,535 in stock - Investing.com India
High Growth Stocks Insiders Are Eager To Own - Simply Wall St
Organogenesis (NASDAQ:ORGO) Trading 9.1% Higher on Analyst Upgrade - Defense World
Organogenesis Holdings Reports Strong Q4 Earnings Amid Challenges - TipRanks
Best Growth Stocks To Watch Now – March 1st - Defense World
The Gross Law Firm Announces Class Actions on Behalf of Shareholders of ORGO, MARA and OSH - ACCESS Newswire
Best Small Cap Stocks To Follow NowMarch 2nd - MarketBeat
Small Cap Stocks To Keep An Eye OnMarch 1st - MarketBeat
Best Growth Stocks To Watch NowMarch 1st - MarketBeat
There's No Escaping Organogenesis Holdings Inc.'s (NASDAQ:ORGO) Muted Revenues Despite A 69% Share Price Rise - Simply Wall St
Organogenesis (NASDAQ:ORGO) Sets New 52-Week High – Here’s What Happened - Defense World
Promising Growth Stocks To ConsiderFebruary 28th - MarketBeat
ORGO stock touches 52-week high at $4.64 amid market fluctuations By Investing.com - Investing.com South Africa
CGI Inc. (GIB) Stock Forecasts - Yahoo Finance
Organogenesis (NASDAQ:ORGO) Issues Earnings Results - MarketBeat
United States shares higher at close of trade; Dow Jones Industrial Average up 1.39% - Investing.com India
U.S. stocks higher at close of trade; Dow Jones Industrial Average up 1.39% - Investing.com
ORGO stock touches 52-week high at $4.64 amid market fluctuations - Investing.com
Today’s top stories: pain management innovation and revenue jumps - RagingBull
Cantor Fitzgerald lifts Organogenesis price target to $6.00 By Investing.com - Investing.com Canada
Cantor Fitzgerald lifts Organogenesis price target to $6.00 - Investing.com
Organogenesis Holdings Inc Stock (ORGO) Financials Data
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):